Neuphoria Therapeutics Inc (NEUP) — Cash Flow Quality Index

Latest as of December 2025: -3.45x

Neuphoria Therapeutics Inc (NEUP) has a Cash Flow Quality Index of -3.45x as of December 2025. Operating cash flow of $-6.44 Million is below net income of $1.86 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NEUP long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-3.45x
Operating CF / Net Income

Operating Cash Flow

$-6.44 Million
USD

Net Income

$1.86 Million
USD

Data as of

Dec 2025
Most recent filing

Annual Cash Flow Quality Index for Neuphoria Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Neuphoria Therapeutics Inc. For live market cap and the full company financial profile, see Neuphoria Therapeutics Inc (NEUP) total market value.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.